ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 0469 • ACR Convergence 2024

    SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

    Cristina Campos Fernández1, Jorge Juan Fragío Gil2, Roxana González Mazario3, Pablo Martínez Calabuig4, Laura Salvador Maicas5, Mireia Lucía Sanmartín Martínez6, Iván Jesús Lorente Betanzos6, Clara Molina Almela6, juan José Lerma Garrido7, Amalia Rueda3 and Jose A Román-Ivorra8, 1Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, 2Hospital General Universitario, Valencia, Comunidad Valenciana, Spain, 3Hospital General de Valencia, Valencia, Comunidad Valenciana, Spain, 4HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN, Ontinyent, Comunidad Valenciana, Spain, 5Consorcio Hospital General Universitario de Valencia, Castellón de la Plana, Comunidad Valenciana, Spain, 6Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, 7Hospital General Universitario Valencia, Valencia, Comunidad Valenciana, Spain, 8Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain

    Background/Purpose: Rheumatoid arthritis (RA) escalates the risk of premature mortality, predominantly through cardiovascular diseases. Although SCORE and its updated version, SCORE2, are employed to assess…
  • Abstract Number: 1329 • ACR Convergence 2024

    Investigating Predictors of Transfusion in Rheumatoid Arthritis and Osteoarthritis Patients Undergoing Knee Arthroplasty

    Stephen Batter1, Huong Do1, Dongmei Sun2, Ahmed Deeb1, Trang Bui1, Jason Blevins1, Mark Figgie1, Gwo-Chin Lee1, J. Alex B. Gibbons3, Bella Mehta4, Susan Goodman5 and Linda A Russell1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Birmingham, AL, 3Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, New York 10025, NY

    Background/Purpose: Use of ambulatory surgery in arthroplasty is increasing, but the need for transfusion mandates hospital admission. Despite the significant drop in transfusion rate linked…
  • Abstract Number: 2026 • ACR Convergence 2024

    Cardiovascular Risk Measured by PREVENT Calculator and Disease Activity in Patients with Systemic Lupus Erythematosus

    Rebeca L. Polina-Lugo1, Aleydis Gonzalez Melendez1, Maria F. Elizondo-Benitez2, Andrea Guajardo Aldaco1, Annette Dominguez-Guerra3, Victoria P. Limas-Martínez1, Iris Jazmín Colunga Pedraza1, Dionicio Galarza-Delgado4, jose Ramon Azpiri-Lopez5, Rosa Icela Arvizu-Rivera1 and Jesus Cardenas-de la Garza6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 6Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

    Background/Purpose: Increased disease activity by SLEDAI (Systemic Erythematosus Lupus Disease Activity Index) has been associated with higher cardiovascular risk (CVR) and atherosclerotic cardiovascular disease (ASCVD),…
  • Abstract Number: 0492 • ACR Convergence 2024

    A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation

    Michael Dreyfuss1, Yonatan Jenudi2, Dan Riesel3, Or Ramni3, Daniel Underberger4, Benjamin Getz5, Shlomit Steinberg-Koch3, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2[email protected], Ramat Gan, Israel, 3Predicta Med Analytics Ltd., Ramat Gan, Israel, 4Predicta Med Analytics Ltd., Bridgeport, CT, 5CTO, Ramat Gan, Israel, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis often experience clinically significant delays in diagnosis (Sørensen et al., 2015; Raza et al., 2011). RA can present similarly to…
  • Abstract Number: 1334 • ACR Convergence 2024

    Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)

    Kylie Riggles1, Hannah Brubeck2, Riley Bass3, Courtney Loecker4, Punyasha Roul5, Bryant England6, Elizabeth Wahl7, James Andrews8, Namrata Singh9, Joshua Baker10, Patti Katz11, Dolores Shoback12, Jose Garcia13, ariela orkaby14 and Katherine Wysham15, 1VA Puget Sound Health Care System, Bellevue, WA, 2VA Puget Sound Health Care System, Seattle, WA, 3VA Puget Sound Health Care System, Gig Harbor, WA, 4University of Nebraska, Lincoln, NE, 5UNMC, Omaha, NE, 6University of Nebraska Medical Center, Omaha, NE, 7VA Puget Sound Healthcare System, Seattle, WA, 8University of Alabama at Birmingham, Birmingham, AL, 9University of Washington, Bellevue, WA, 10University of Pennsylvania, Philadelphia, PA, 11UCSF, San Rafael, CA, 12San Francisco VA/University of California, San Francisco, San Francisco, CA, 13VA Puget Sound Health Care System/University of Washington, Seattle, WA, 14New England VA Geriatric Research Education and Clinical Center/Boston VA/Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 15VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

    Background/Purpose: Frailty is a state of decreased physiological reserve that confers an increased vulnerability to stressors and adverse outcomes1. Compared to the general population, frailty…
  • Abstract Number: 2097 • ACR Convergence 2024

    Application of Machine Learning Methods to Predict the Risk of Rapid Pain Progression in Patients with Knee OA. Study Using Patients from the OAI and PROCOAC

    Ignacio Rego-Perez1, Isabel Rodriguez-Valle2, Juan Fernández-Tajes2, Vanesa Balboa-Barreiro3, Carlota Fraga-Seijas2, María del carmen de andres2, Valentina Calamia2, Patricia Fernández-Puente4, Nicola Veronese5, Cristina Ruiz-Romero6, Natividad Oreiro7 and francisco J Blanco8, 1Instituto de Investigacion Biomedica de A Coruña-SERGAS, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña UDC. As XUbias, 15006. A Coruña, España, A Coruña, Spain, 3Unidad de Epidemiología Clínica y Bioeostadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC)., A Coruña, Spain, 4Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, Spain, 5Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy, A Coruña, Spain, 6INIBIC - CHUAC, A Coruña, Spain, 7CHUAC, La Coruna, Galicia, Spain, 8INIBIC-University of A Coruña, A Coruña, Spain

    Background/Purpose: There is a need to design models based on machine learning that are capable of predicting the risk of rapid pain progression of knee…
  • Abstract Number: 0498 • ACR Convergence 2024

    ACPA Subtypes, RF Isotypes, and the Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Jacob Welch1, Yangyuna Yang1, Joshua Baker2, Katherine Wysham3, Dana Ascherman4, Paul Monach5, Gail Kerr6, Andreas Reimold7, grant Cannon8, Gary Kunkel9, William Robinson10, Michael Duryee1, Geoffrey Thiele1, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 5VA Boston Healthcare System, Boston, MA, 6Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 7Dallas VA Medical Center, Dallas, TX, 8University of Utah and Salt Lake City VA, Salt Lake City, UT, 9University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 10Stanford University, Palo Alto, CA

    Background/Purpose: Interstitial lung disease (ILD) is among the most significant extra-articular manifestations of rheumatoid arthritis (RA), clinically affecting 8-15% of RA patients, and accounting for…
  • Abstract Number: 1336 • ACR Convergence 2024

    Risk of Malignancy Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database

    Ryoko Sakai1, Eiichi Tanaka2, Eisuke Inoue3 and Masayoshi Harigai4, 1Meiji Pharmaceutical University, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan, 3Showa University, Tokyo, Japan, 4Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Janus kinase inhibitors (JAKIs) have shown positive therapeutic impacts on treatments for rheumatoid arthritis (RA), whereas, there are concerns about the risk of malignancy…
  • Abstract Number: 2125 • ACR Convergence 2024

    Strengthening Fracture Risk Prediction in Rheumatoid Arthritis: Integrating a Self-report Sarcopenia Screening Tool (SARC-F) and Fracture Risk Assessment Tool (FRAX) Scores

    Ana Rodriguez-Flores1, Ana Cecilia Bardan-Inchaustegui2, Mara Ponce2, Galilea Rodriguez3, Anahí Carrazco Chapa4, Valeria Monserrat De Hoyos-Perez5, Gilberto J Cervantes Charles5, Alma Damian Peñaloza5, Cinthia Maribel Cortez Lopez5, CASSANDRA SKINNER TAYLOR6, Roberto Negrete Lopez5, Jesus Cardenas-de la Garza2 and Dionicio Galarza-Delgado7, 1Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 6HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of fractures due to factors such as chronic inflammation, use of glucocorticoids, and reduced muscle mass.…
  • Abstract Number: 0564 • ACR Convergence 2024

    The Risk of Venous Thromboembolism in Axial Spondyloarthritis: A Population-based Study

    Mayas Arraf1, Devy Zisman2, walid Saliba3, Nili Stein4 and Joy Feld5, 1Technion medical school, Haifa, Israel, 2Carmel Medical Center, Haifa, Israel, 3Carmel medical center, Haifa, Israel, 4Department of Community Medicine and Epidemiology, Haifa, Israel, 5Carmel and Zvulun Medical Centre, Haifa, Israel

    Background/Purpose: Scarce data exist regarding the incidence of venous thromboembolism events (VTE); pulmonary embolism (PE) and deep vein thrombosis (DVT), in patients with axial spondylarthritis…
  • Abstract Number: 1347 • ACR Convergence 2024

    Interest of DAS28-γGT in Assessing Cardiovascular Risk Activity in Rheumatoid Arthritis in Routine Practice

    Manon Lesturgie-Talarek1, Fabien Picard2, sabrina hamroun3, Malika Saadi2, Camille Macher4, Aude Deloumeau3, Karim Wahbi2, jacques Blacher4, Yannick Allanore5 and Jérôme Avouac6, 1Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, France, 2Cardiology Department - Cochin Hospital, Paris, France, 3Rheumatology Department - Cochin Hospital, Paris, France, 4Cardiology Department, Hôtel Dieu Hospital, Paris, France, 5Université Paris Cité, Paris, France, 6Rheumatology A Department, Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular (CV) mortality, linked to systemic inflammation and the presence of associated CV risk factors.…
  • Abstract Number: 2235 • ACR Convergence 2024

    The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis

    J. Alex B. Gibbons1, Joan Bathon2 and Jon Giles3, 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Columbia University, NEW YORK, NY, 3Cedars Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Patients with RA are at increased risk of atherosclerotic cardiovascular disease (ASCVD), yet traditional 10-year CVD risk calculators—such as the 2013 Pooled Cohort Equations…
  • Abstract Number: 0612 • ACR Convergence 2024

    Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI): Results from the Egyptian College of Rheumatology (ECR) Study Cohort

    Nevin Hammam1, Ahmed Elsaman2, Esam Abualfadl3, Soha Senara4, Nada M. Gamal5, Mona H. Abd Elsamea5, Abdelhfeez Moshrif6, Samar Tharwat7, Osman Hammam8 and Tamer A Gheita9, 1Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, Boston, MA, 2Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt, 3Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt; Qena/Luxor Hospitals, Qena, Egypt, Sohag, Egypt, 4Rheumatology Department, Faculty of Medicine, Fayoum University,, Fayoum, Egypt, 5Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, Assiut, Egypt, 6Al-azhar university, Assiut, Egypt, 7Rheumatology Unit, Internal Medicine, Mansoura University, Dakahlia, 8Department of Rheumatology and Rehabilitation, Faculty of Medicine, New Valley University, New Valley, Assiut, Egypt, 9Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by a great heterogeneity and unpredictable flare. In managing patients with SLE, the diagnosis…
  • Abstract Number: 1505 • ACR Convergence 2024

    Incidence of Cardiovascular and Venous Thromboembolic Events in Four Autoantibody-defined Systemic Lupus Erythematosus Clusters

    Sara Ferrigno1, Elizabeth Arkema2, Lina Marcela Diaz-Gallo3, Iva Gunnarsson4, Agneta Zickert4 and Elisabet Svenungsson5, 1Department of Systems' Medicine, University of Rome Tor Vergata, Rome, Italy, 2Department of Medicine Solna, Clinical Epidemiology Division, Stockholm, Sweden, 3Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 4Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 5Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Systemic lupus erythematosus (SLE) patients have higher cardiovascular (CV) risk compared to the general population, with a standardized CV mortality rate of 2-3 and…
  • Abstract Number: 2326 • ACR Convergence 2024

    Development and Evaluation of a Machine Learning Model for the Early Identification of Psoriatic Arthritis

    Michael Dreyfuss1, Dan Riesel2, Guy Shalev2, Benjamin Getz3, Or Ramni2, Yonatan Jenudi4, Dimid Duchovny2, Daniel Underberger5, Shlomit Steinberg-Koch2, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2Predicta Med Analytics Ltd., Ramat Gan, Israel, 3CTO, Ramat Gan, Israel, 4[email protected], Ramat Gan, Israel, 5Predicta Med Analytics Ltd., Bridgeport, CT, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Delays in diagnosis of psoriatic arthritis (PsA) are associated with indolent and non-specific signs and symptoms, and often result in physical impairment and poorer…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology